Multisite Quality Improvement Program Within the Project ECHO Diabetes Remote Network
Copyright © 2023 The Joint Commission. Published by Elsevier Inc. All rights reserved..
BACKGROUND: The telementoring Project ECHO (Extension for Community Healthcare Outcomes) model has been shown to improve disease management in diabetes in many underserved communities. The authors aim to evaluate if ECHO could also be an effective tool for quality improvement (QI) of diabetes care in these communities.
METHODS: Thirteen clinics in underserved communities in California and Florida participating in Project ECHO Diabetes were recruited for a 12-month QI program. The program provided weekly tele-education sessions, including a didactic presentation and case-based discussion. In addition, clinics chose their own set of quality measures to improve and met remotely to discuss their efforts, successes, and setbacks every quarter with mentorship from QI experts.
RESULTS: Of the 31 QI initiatives attempted by different clinics, all had either made improvements (25 initiatives, 80.6%) or were in the process of making improvements (6 initiatives, 19.4%) in structural, process, and outcome measures. Examples of these measures include whether clinics have protocols to identify high-risk patients (structure), numbers of continuous glucose monitor prescriptions submitted by the clinics (process), and percentage of patients with diabetes whose most recent HbA1c are > 9% (outcome). For one measure, 40.0% of the clinics had achieved a higher percentage of cumulative HbA1c measurement in the third quarter of the year, compared to the fourth quarter in the previous year. The cost of QI implementation varied widely due to different number of personnel involved across sites.
CONCLUSION: A QI program delivered via Project ECHO Diabetes can facilitate quality improvements in underserved communities.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:50 |
|---|---|
| Enthalten in: |
Joint Commission journal on quality and patient safety - 50(2024), 1 vom: 23. Jan., Seite 66-74 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Wang, C Jason [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Completed 05.01.2024 Date Revised 05.04.2024 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.jcjq.2023.08.001 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM362151660 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM362151660 | ||
| 003 | DE-627 | ||
| 005 | 20240405233125.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.jcjq.2023.08.001 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1366.xml |
| 035 | |a (DE-627)NLM362151660 | ||
| 035 | |a (NLM)37718146 | ||
| 035 | |a (PII)S1553-7250(23)00191-5 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Wang, C Jason |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Multisite Quality Improvement Program Within the Project ECHO Diabetes Remote Network |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 05.01.2024 | ||
| 500 | |a Date Revised 05.04.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2023 The Joint Commission. Published by Elsevier Inc. All rights reserved. | ||
| 520 | |a BACKGROUND: The telementoring Project ECHO (Extension for Community Healthcare Outcomes) model has been shown to improve disease management in diabetes in many underserved communities. The authors aim to evaluate if ECHO could also be an effective tool for quality improvement (QI) of diabetes care in these communities | ||
| 520 | |a METHODS: Thirteen clinics in underserved communities in California and Florida participating in Project ECHO Diabetes were recruited for a 12-month QI program. The program provided weekly tele-education sessions, including a didactic presentation and case-based discussion. In addition, clinics chose their own set of quality measures to improve and met remotely to discuss their efforts, successes, and setbacks every quarter with mentorship from QI experts | ||
| 520 | |a RESULTS: Of the 31 QI initiatives attempted by different clinics, all had either made improvements (25 initiatives, 80.6%) or were in the process of making improvements (6 initiatives, 19.4%) in structural, process, and outcome measures. Examples of these measures include whether clinics have protocols to identify high-risk patients (structure), numbers of continuous glucose monitor prescriptions submitted by the clinics (process), and percentage of patients with diabetes whose most recent HbA1c are > 9% (outcome). For one measure, 40.0% of the clinics had achieved a higher percentage of cumulative HbA1c measurement in the third quarter of the year, compared to the fourth quarter in the previous year. The cost of QI implementation varied widely due to different number of personnel involved across sites | ||
| 520 | |a CONCLUSION: A QI program delivered via Project ECHO Diabetes can facilitate quality improvements in underserved communities | ||
| 650 | 4 | |a Journal Article | |
| 650 | 7 | |a Glycated Hemoglobin |2 NLM | |
| 650 | 7 | |a Blood Glucose |2 NLM | |
| 700 | 1 | |a Lewit, Eugene M |e verfasserin |4 aut | |
| 700 | 1 | |a Clark, Catherine L |e verfasserin |4 aut | |
| 700 | 1 | |a Lee, Fu-Shiuan Whitney |e verfasserin |4 aut | |
| 700 | 1 | |a Maahs, David M |e verfasserin |4 aut | |
| 700 | 1 | |a Haller, Michael James |e verfasserin |4 aut | |
| 700 | 1 | |a Addala, Ananta |e verfasserin |4 aut | |
| 700 | 1 | |a Lal, Rayhan A |e verfasserin |4 aut | |
| 700 | 1 | |a Cuttriss, Nicolas |e verfasserin |4 aut | |
| 700 | 1 | |a Baer, Linda G |e verfasserin |4 aut | |
| 700 | 1 | |a Figg, Lauren E |e verfasserin |4 aut | |
| 700 | 1 | |a Añez-Zabala, Claudia |e verfasserin |4 aut | |
| 700 | 1 | |a Sheehan, Eleni P |e verfasserin |4 aut | |
| 700 | 1 | |a Westen, Sarah C |e verfasserin |4 aut | |
| 700 | 1 | |a Bernier, Angelina V |e verfasserin |4 aut | |
| 700 | 1 | |a Donahoo, William Troy |e verfasserin |4 aut | |
| 700 | 1 | |a Walker, Ashby Farmer |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Joint Commission journal on quality and patient safety |d 2005 |g 50(2024), 1 vom: 23. Jan., Seite 66-74 |w (DE-627)NLM153492597 |x 1938-131X |7 nnns |
| 773 | 1 | 8 | |g volume:50 |g year:2024 |g number:1 |g day:23 |g month:01 |g pages:66-74 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.jcjq.2023.08.001 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 50 |j 2024 |e 1 |b 23 |c 01 |h 66-74 | ||